TRP_1170x120_3-8-19

PCSK9 inhibitors

CVS researchers re-examine cholesterol treatments

WOONSOCKET, R.I. — CVS Health Research Institute experts have urged cardiologists to consider changing their treatment guidelines for patients with high cholesterol as a new class of high-cost medications arrives on the market. A commentary published online in the Journal of the American Medical Association on August 10 argued that the new cholesterol-lowering drugs, known

CVS Health: Rx therapy for high cholesterol needs review

CVS Health: Rx therapy for high cholesterol needs review

WOONSOCKET, R.I. — The cardiology community should review and reconsider current treatment guidelines for the management of high cholesterol, according to experts at the CVS Health Research Institute. In a commentary published online Monday in the Journal of the American Medical Association (JAMA), the CVS Health experts said that as PCSK9 inhibitors — a new